Rubius Therapeutics Buy Hold or Sell Recommendation
| RUBYDelisted Stock | USD 0.08 0.02 17.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Rubius Therapeutics is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Rubius Therapeutics given historical horizon and risk tolerance towards Rubius Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Rubius Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. In addition, we conduct extensive research on individual companies such as Rubius and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Rubius Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Rubius |
Execute Rubius Therapeutics Buy or Sell Advice
The Rubius recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Rubius Therapeutics. Macroaxis does not own or have any residual interests in Rubius Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Rubius Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Rubius Therapeutics Trading Alerts and Improvement Suggestions
| Rubius Therapeutics is not yet fully synchronised with the market data | |
| Rubius Therapeutics has some characteristics of a very speculative penny stock | |
| Rubius Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (179.67 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Rubius Therapeutics currently holds about 140.71 M in cash with (150.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.56, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 73.0% of the company shares are owned by institutional investors |
Rubius Therapeutics Returns Distribution Density
The distribution of Rubius Therapeutics' historical returns is an attempt to chart the uncertainty of Rubius Therapeutics' future price movements. The chart of the probability distribution of Rubius Therapeutics daily returns describes the distribution of returns around its average expected value. We use Rubius Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Rubius Therapeutics returns is essential to provide solid investment advice for Rubius Therapeutics.
| Mean Return | -0.55 | Value At Risk | -20 | Potential Upside | 21.74 | Standard Deviation | 13.32 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Rubius Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Rubius Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Rubius . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Rubius Therapeutics Buy or Sell Advice
When is the right time to buy or sell Rubius Therapeutics? Buying financial instruments such as Rubius Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Rubius Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cryptocurrency ETFs Thematic Idea Now
Cryptocurrency ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Cryptocurrency ETFs theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cryptocurrency ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in Rubius Pink Sheet
If you are still planning to invest in Rubius Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rubius Therapeutics' history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |